Leonie Bourauel None;
Marc Vaisband None;
Leon von der Emde None;
Katharina Bermond None;
Ioana Tarau Alimera, Novartis, Code C (Consultant/Contractor);
Marlene Sassmannshausen Heidelberg Engineering, CenterVue, Carl Zeiss MedicTec, Code F (Financial Support);
Rainer Heintzmann Zeiss, Code C (Consultant/Contractor), Zeiss, Code F (Financial Support);
Frank Holz Acucela, Apellis, Bayer, Boehringer-Ingelheim, Bioeq/Formycon, Roche/Genentech, Geuder, Graybug, Gyroscope, Heidelberg Engineering, IvericBio, Kanghong, LinBioscience, Novartis, Oxurion, Pixium Vision, Stealth BioTherapeutics, Zeiss, Code C (Consultant/Contractor), Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, CenterVue, Ellex, Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, Kanghong, NightStarX, Novartis, Optos, Pixium Vision, Zeiss, Code F (Financial Support);
Christine Curcio Genentech, Heidelberg Engineering, Regeneron, Code F (Financial Support), MacRegen Inc., Code I (Personal Financial Interest);
Jan Hasenauer None;
Thomas Ach Roche, Novartis, Code C (Consultant/Contractor), MacRegen Inc., Code I (Personal Financial Interest), Novartis, Code R (Recipient)